Preview

Problems of Particularly Dangerous Infections

Advanced search

F(ab’)2-Fragments of Antirabic Immunoglobulin Production Using Immobilized Pepsin

https://doi.org/10.21055/0370-1069-2008-3(97)-53-56

Abstract

Biotechnological scheme for F(ab')2-fragments of anti-rabies immunoglobulin production using immobilized pepsin was developed. Optimal ways for immobilized pepsin production were determined, conditions for fermentative hydrolysis of anti-rabies immunoglobulin were sorted out. Protective properties of F(ab')2-fragments of anti-rabies immunoglobulin produced by means of this method were assessed.

About the Authors

S. V. Generalov
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


E. G. Abramova
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


A. K. Nikiforov
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


E. M. Hramkova
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


I. A. Shepelev
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


L. V. Savitskaya
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


L. N. Minaeva
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


M. V. Galkina
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


T. A. Miheeva
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


N. N. Kochkalova
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


M. N. Kireev
Russian Anti-Plague Institute "Microbe", Saratov
Russian Federation


References

1. Алсынбаев М.М., Исрафилов А.Г., Баталова Т.А. и др. Избранные вопросы сывороточного производства. Актуальные вопросы разработки, производства и применения иммунобиологических и фармацевтических препаратов. Уфа; 2000. Ч. 1. С. 108-16.

2. Кушманова О.Д., Ивченко Г.М. Руководство к лабораторным занятиям по биологической химии. М.: Медицина; 1983. С. 175-6.

3. Каплан М.М., Копровски Н., редакторы. Методы лабораторных исследований по бешенству. Третье издание. Женева: ВОЗ; 1975. 360 с.

4. Методы контроля медицинских иммунобиологических препаратов, вводимых людям: Методические указания. М.: Информационно-издательский центр Минздрава России; 1998. 128 с.

5. Райхер Л.И., Райхер И.И., Фарцейгер Н.Л. и др., изобретатели. Способ получения иммобилизованного коммерческого пепсина. А.с. № 1730148 СССР, МКИ С12N11/14; 30.04.1992.

6. Chen L., Tsao G. Chemical procedures for enzyme immobilization on porous cellulose beads. Biotechnol. Bioeng. 1977; 19:1463-1473.

7. Hong H., Rooijakkers E., Ke N. et al. Methods for the purification of equine rabies immunoglobulin: effects on yield and biological activity. Biologicals. 1994; 22:1-6.

8. Lang J., Attanath P., Quiambao B. et al. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Acta Trop.1998; 70:317-333.

9. Lu J., Guo Z., Han W. et al. Preparation and development of equine hyperimmune globulin F(ab')2 against severe acute respiratory syndrome coronavirus. Acta Pharmacol. Sin. 2005; 26:1479-84.

10. Puvanakrishnan R., Bose S. Immobilization of pepsin on sand: preparation, characterization and application. Indian J. Biochem. Biophys. 1984; 21:323-326.

11. Sannier F., Piot J.M., Guillochon D. et al. Stabilization of pepsin on duolite for continuos hydrolysis of bovine haemoglobin at pH 2 and 40 °C. Biotechnology techniques. 1993; 7(1):25-30.

12. Tomono T., Suzuki T., Tokunaga E. Cleavage of human serum immunoglobulin G by immobilized pepsin preparation. Biochim. Biophys. Acta. 1981; 660:186-192.

13. WHO Expert Consultation on Rabies: first report. Geneva; 2004. 121 p.


Review

For citations:


Generalov S.V., Abramova E.G., Nikiforov A.K., Hramkova E.M., Shepelev I.A., Savitskaya L.V., Minaeva L.N., Galkina M.V., Miheeva T.A., Kochkalova N.N., Kireev M.N. F(ab’)2-Fragments of Antirabic Immunoglobulin Production Using Immobilized Pepsin. Problems of Particularly Dangerous Infections. 2008;(3(97)):53-56. (In Russ.) https://doi.org/10.21055/0370-1069-2008-3(97)-53-56

Views: 504


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0370-1069 (Print)
ISSN 2658-719X (Online)